Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation
Explore this paper's citation graph
Summary
A large casecontrol study evaluated the relationship of increasing age and INR to the risk for intracranial hemorrhage among patients with nonvalvular atrial fibrillation and patients receiving anticoagulation who did not develop intracerebral hemorrhage.
- Type
- article
- Published
- 2004-11-16
- Cited by
- 571
- References
- 47
- OpenAlex
- https://openalex.org/W1986506316
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:30002726
Keywords
Medicine, Atrial fibrillation, Odds ratio, Warfarin, Internal medicine
References
- A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
- Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses.
- Physician Attitudes Concerning Warfarin for Stroke Prevention in Atrial Fibrillation: Results of a Survey of Long‐Term Care Practitioners
- The Framingham study.
- Long-term prognosis after recovery from primary intracerebral hemorrhage
- Aspirin use and incident stroke in the cardiovascular health study. CHS Collaborative Research Group.
- The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
- Optimal oral anticoagulant therapy in patients with mechanical heart valves.
- Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy.
- Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota.
- Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).
- Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.
- Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke
- Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
- Clinical Features and Functional Outcome of Intracerebral Hemorrhage in Patients Aged 85 and Older
- Clinical Predictors of Prolonged Delay in Return of the International Normalized Ratio to within the Therapeutic Range after Excessive Anticoagulation with Warfarin
- Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
- Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.
- Warfarin-associated hemorrhage and cerebral amyloid angiopathy
- National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.
Cited by
- Haemorrhagic Complications of Vitamin K Antagonists in the Elderly
- The risk of bleeding with anticoagulant treatments
- Antiplatelet versus anticoagulant therapies in advanced age: an unfinished task.
- Predicting the outcomes of acute ischaemic stroke in atrial fi brillation: the role of baseline CHADS2, CHA2DS2-VASC and HAS-BLED score values
- Self-monitoring of oral anticoagulation: does it work outside trial conditions?
- Preemptive dose reduction of warfarin in patients initiating metronidazole
- Clinical experience with oral versus intravenous vitamin K for warfarin reversal (CME)
- Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice.
- Management of bleeding in patients treated with direct oral anticoagulants
- Racial/ethnic variation of APOE alleles for lobar intracerebral hemorrhage
- Melhora de anticoagulação oral crônica após o manejo guiado pela vitamina K da dieta : ensaio clinico randomizado
- Requirements for a patient self monitoring service for oral anticoagulation
- PINCER trial: a cluster randomised trial comparing the effectiveness and cost-effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices
- Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis.
- Évolution dans la prise en charge des accidents hémorragiques liés aux antivitamines K et traités par du concentré de complexes prothrombiniques : la gestion du traitement médicamenteux par les urgentistes s’est-elle améliorée au fil du temps ?
- Antikoagulation zur Schlaganfallprävention
- Evidence-based case report: Orale antistolling bij oudere patiënten en het risico op intracraniële bloedingen
- The role of community pharmacy in post-discharge warfarin management
- Kostnaden för förmaksflimmer i Östergötland
- Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED score.
Related papers
- The utilization status of aspirin for the secondary prevention of ischemic stroke
- Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease.
- Evaluation of the Effectiveness of the AggreGuide A-100 in Measuring Platelet Aggregation in Individuals Taking a High or Low Dose of Aspirin
- Letter: Crushed aspirin tablets.
- Warfarin and aspirin give more benefit than aspirin alone but also more bleeding after myocardial infarction
- The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study.
- THE ROLE OF ASPIRIN AND WARFARIN IN IHD PREVENTION.
- Drug Interactions and Risk of Bleeding among Patients with Atrial Fibrillation (AF) Discharged with Warfarin
- Also the very elderly benefit from warfarin in atrial fibrillation